Catalogo dei prodotti della ricerca

BARATTA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.274
EU - Europa 1.436
AS - Asia 939
SA - Sud America 69
AF - Africa 21
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.747
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.235
IT - Italia 792
SG - Singapore 520
CN - Cina 151
IN - India 151
DE - Germania 102
SE - Svezia 100
BG - Bulgaria 73
RU - Federazione Russa 67
FI - Finlandia 59
IE - Irlanda 49
BR - Brasile 47
ID - Indonesia 41
GB - Regno Unito 40
FR - Francia 34
CA - Canada 32
NL - Olanda 25
JO - Giordania 24
RO - Romania 19
AT - Austria 17
UA - Ucraina 15
AR - Argentina 14
TR - Turchia 14
BE - Belgio 12
TG - Togo 12
AU - Australia 7
PL - Polonia 7
CH - Svizzera 6
GR - Grecia 6
HK - Hong Kong 6
PH - Filippine 6
TN - Tunisia 6
ES - Italia 4
IQ - Iraq 4
MX - Messico 4
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BO - Bolivia 2
CL - Cile 2
JM - Giamaica 2
KG - Kirghizistan 2
MY - Malesia 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BH - Bahrain 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
MM - Myanmar 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.747
Salva come PNG Salva come JPEG
Città #
Fairfield 538
Rome 317
Singapore 245
Woodbridge 235
Ashburn 234
Seattle 212
Houston 199
Chandler 186
Cambridge 183
Wilmington 168
Ann Arbor 129
Dearborn 102
Princeton 88
San Paolo di Civitate 80
Santa Clara 77
Sofia 72
Beijing 61
Millbury 57
Fremont 56
Lawrence 56
Dublin 49
Cosenza 43
Plano 42
Jakarta 40
New York 37
Helsinki 28
San Diego 28
Milan 26
Andover 23
Bremen 21
Nuremberg 20
Amman 19
Moscow 19
Boston 18
Norwalk 17
Toronto 14
London 13
Mannheim 13
Ottawa 13
Phoenix 13
Lomé 12
Brussels 10
Samsun 10
Vienna 10
Boardman 9
Falkenstein 9
Glendale 9
Los Angeles 9
Amsterdam 8
Bologna 8
Dallas 8
Naples 8
Rochester 8
Falls Church 7
Federal 7
Frankfurt am Main 7
Hyderabad 7
Redwood City 7
Council Bluffs 6
Geneva 6
Hong Kong 6
Nanjing 6
San Severo 6
Southend 6
Bari 5
Buenos Aires 5
Des Moines 5
Fuzhou 5
Kunming 5
Megrine 5
Monterotondo 5
Sacramento 5
Stockholm 5
Velletri 5
Yubileyny 5
Zarqa 5
Arezzo 4
Asti 4
Bermondsey 4
Cagliari 4
Cascina 4
Florence 4
Genoa 4
Hefei 4
Marseille 4
Menlo Park 4
Mesa 4
Paris 4
Pescara 4
Sabaudia 4
Salerno 4
Surat 4
Turin 4
Baghdad 3
Bovezzo 3
Bromley 3
Campinas 3
Catania 3
Chengdu 3
Grafing 3
Totale 4.129
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 177
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation. the ARAPACIS study 175
Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis 156
Adherence to mediterranean diet and non-alcoholic fatty liver disease. effect on insulin resistance 128
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 124
Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy 113
PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress 106
Off-label use of ceftaroline fosamil: a systematic review 104
Under-prescription of statins in patients with non-alcoholic fatty liver disease 102
Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome 102
Severity of OSAS, CPAP and cardiovascular events: a follow-up study 100
Overexpression of the vitronectin v10 subunit in patients with nonalcoholic steatohepatitis: Implications for noninvasive diagnosis of NASH 99
Reduced lysosomal acid lipase activity in blood and platelets is associated with nonalcoholic fatty liver disease 99
Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage 98
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study 98
Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study 98
Similar reduction of cholesterol-adjusted Vitamin E serum levels in simple steatosis and non-alcoholic steatohepatitis 97
Progressive reduction of blood lysosomal acid lipase activity according to stage of adult chronic liver disease and altered enzymatic cellular distribution in cirrhosis 97
Relation of Nonalcoholic Fatty Liver Disease and Framingham Risk Score to Flow-Mediated Dilation in Patients With Cardiometabolic Risk Factors 95
Oxidative stress: new insights on the association of nonalcoholic fatty liver disease and atherosclerosis 95
Twelve variants polygenic score for low-density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with or without causative mutations 93
Effects of dark chocolate on endothelial function in patients with non-alcoholic steatohepatitis 92
Reduced lysosomal acid lipase activity in adult patients with non-alcoholic fatty liver disease 90
P848 SERUM CYTOKERATIN-18 IS ASSOCIATED WITH OXIDATIVE STRESS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 88
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants 87
Obesity and Hypercholesterolemia are Associated with NOX2 Generated Oxidative Stress and Arterial Dysfunction 85
Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease 84
Increased liver localization of lipopolysaccharides in human and experimental NAFLD 84
Post-Implantation Syndrome. The impact of different devices for endovascular abdominal aortic aneurysm repair and related etiopathogenetic implications 81
Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease 78
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review 78
Incidence of post-implantation syndrome with different endovascular aortic aneurysm repair modalities and devices and related etiopathogenetic implications 77
Non-alcoholic fatty liver disease and cardiovascular disease: Epidemiological, clinical and pathophysiological evidences 77
Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease? 76
Statins and non-alcoholic fatty liver disease 76
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation 75
Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment 73
Sex-related differences in the association between metabolic syndrome and gallstone disease 73
Moderate weight loss decreases oxidative stress and increases antioxidant status in patients with metabolic syndrome 72
The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease 72
Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet 71
Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose 71
The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease 69
Poor adherence to mediterranean diet and serum lipopolysaccharide are associated with oxidative stress in patients with non-alcoholic fatty liver disease 69
Correction to: Reduced lysosomal acid lipase activity in blood and platelets Is associated with nonalcoholic fatty liver disease 69
Current Ways of Treating Dyslipidemias to Prevent Atherosclerosis 68
HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (NAFLD) 68
New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress 66
Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver 64
Assessment of hepatic fibrosis in MAFLD..a new player in the evaluation of residual cardiovascular risk 62
Obstructive Sleep Apnea and the Metabolic Syndrome: Pathophysiological and Clinical Evidence 61
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease 60
P825 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH REDUCED SERUM CHOLESTEROL-ADJUSTED VITAMIN E LEVELS 59
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis 59
High cardiovascular risk in non-alcoholic fatty liver disease: a possible role for increased oxidative stress. 58
Modern approach to the clinical management of non-alcoholic fatty liver disease 58
The post-implantation syndrome(PIS). The impact of different devices for endovascular abdominal aortic aneurysm repair (EVAR) and related etiopathogenetic implications 58
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. a prospective multicenter cohort study 58
Cholesterol remnants, triglyceride-rich lipoproteins and cardiovascular risk 58
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? 54
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 54
Diet and metabolic syndrome. A narrative review 51
Endotelial dysfunction and increased oxidative stress in patients with obstructive sleep dyspnea. Effect of CPAP therapy. 51
The challenge of cardiovascular prevention in NAFLD 50
NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease 49
Ridotta attività della lipasi acida lisosomiale: un possibile ruolo patogenetico nella nafld? 49
Extra virgin olive oil reduces gut permeability and metabolic endotoxemia in diabetic patients 47
Statin use and mortality in atrial fibrillation. A systematic review and meta-analysis of 100,287 patients 47
The intricacies of the Mediterranean diet in NAFLD. Response to Duret et al 44
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study 43
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 41
Sindrome delle apnee ostruttive del sonno e rischio cardiovascolare 41
PNPLA3 I148M gene variant is not associated with metabolic syndrome and cardiometabolic risk in non-alcoholic fatty liver disease 40
Nonalcoholic fatty liver disease and the kidney: a review 37
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis 37
High compliance to mediterranean diet associates with lower platelet activation and liver collagen deposition in patients with nonalcoholic fatty liver disease 37
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification 36
Open issues in the transition from nafld to mafld. the experience of the plinio study 29
Is the mediterranean diet the best approach to NAFLD treatment today 29
PAD4-Induced NETosis Via Cathepsin G-Mediated Platelet-Neutrophil Interaction in ChAdOx1 Vaccine-Induced Thrombosis-Brief Report 28
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease 28
Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease 27
null 27
Prevention and management of type ii diabetes chronic complications. the role of polyphenols (mini-review) 26
Commentary on "effect of green-mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial" 25
Risk of adverse events in anticoagulated patients with atrial fibrillation and non-alcoholic fatty liver disease 20
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia. insights from the Italian LIPIGEN registry 18
null 17
Oxidative stress mediated platelet activation in patients with congenital analbuminemia. Effect of albumin infusion 16
Influence of uric acid on vascular and cognitive functions: evidence for an ambivalent relationship 13
Lipoprotein(a) genotype influences the clinical diagnosis of familial hypercholesterolemia 12
Challenges in improving adherence to diet and drug treatment in hypercholesterolemia patients 10
Totale 6.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020294 0 0 0 0 0 0 0 0 118 71 71 34
2020/2021704 50 29 20 61 15 73 10 20 63 220 115 28
2021/2022908 22 30 78 49 104 56 17 64 61 67 200 160
2022/2023957 168 201 52 62 72 84 21 119 57 21 63 37
2023/2024737 50 69 37 49 73 141 38 35 19 76 72 78
2024/20251.137 36 84 100 120 104 123 107 121 342 0 0 0
Totale 6.213